Lowering the age and smoking history standards would result in substantially more Blacks and women being eligible for screening.
The United States Preventive Services Task Force (USPSTF) announced proposed changes to its lung cancer screening recommendations today that the task forces estimates would more than double the number of Black Americans eligible for screening and also increase the eligibility of women.
USPSTF is proposing to recommend annual screening for adults, ages 50 to 80, who have a 20 pack-year smoking history and either currently smoke or quit smoking within the past 15 years.
The current recommendation, which dates from 2014, is for annual screening to start five years later, at age 55, and for a history of heavier smoking — 30 pack-years instead of 20.
A pack-year is a common way of measuring a person's exposure to cigarettes and is calculated by counting the number of years that a person has smoked, on average, 20 (the number of cigarettes in a pack) cigarettes a day.
Starting screening at age 50 and including people with lighter smoking histories would increase the number of Americans eligible for lung cancer screening by 86% overall, the task force says in the discussion section of its guidelines.
Among non-Hispanic Blacks, the relative increase would be 105% compared with 77% among non-Hispanic whites, the task force says. There would also a gender difference with the wider eligibility: an 81% relative increase among men compared with a 96% increase among women.
The task force mentions that African American have a higher risk of lung cancer than whites and that the difference in risk is more apparent at lower levels of smoking. It also cites a study that found that 17% of African American smokers were eligible for screening using the 2014 USPSTF recommendations compared with 31% of white smokers.
The proposed updated recommendation and the 2014 recommendation both set 80 as the the upper-age limit for screening. They update also doesn't differ from the 2014 recommendations in saying that lung cancer screening should stop once someone hasn't smoked for 15 years or develops a heart problem that substantially shortens their life expectancy.
Possible harms from lung cancer screening include false positives and related workups, and radiation exposure from the the low-dose CT scans used in screening, according to the task force. Lung cancer screening also results in incidental findings that may lead to more imaging and tests — imaging and tests that may, depending on the finding, be unnecessary and possibly cause harm.
The USPSTF gave its lung cancer screening recommendation a "B" grade, which means it sees a moderate net benefit as being highly certain or has moderate certainty of a moderate-to-substantial benefit.
The task force is accepting public comments on its proposed recommendation till August 3.
Combining Avastin With Alecensa Shows Promise in Advanced ALK-Positive Lung Cancer
May 29th 2025A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain metastases, and improved quality of life in patients with advanced ALK-positive lung cancer.
Read More
ICI-Chemo Combo Delivers More Benefit Than Harm, Even for High-Risk NSCLC Patients, Study Finds
May 16th 2025Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the treatment of non-small cell lung cancer. But it is open question whether they should be combined with traditional chemotherapy.
Read More
Time Well Spent: Lung Cancer Trials Offer Improved Survival Without Added Burden
May 7th 2025Researchers are exploring the topic of "time toxicity" — how much time patients spend receiving care. This study is the first to directly compare time spent in care between clinical trial participants and routine care patients receiving the same treatments.
Read More